NMPA

New York and Suzhou, China, September 8, 2026 Accro Bioscience has announced a major clinical development milestone for AC-201,...

Zhuhai, China — September 7, 2026 Rezubio announced the successful first cohort dosing of RZ-520 in a Phase 1...

Tokyo, Japan and Cambridge, Massachusetts, USA, September 3, 2026 Eisai Co., Ltd. and Biogen Inc. announced that China’s National...

Montreal, Quebec, and Charlotte, North Carolina — September 3, 2026 Milestone Pharmaceuticals announced that China’s National Medical Products Administration...

SHANGHAI, China, Aug 28, 2026 Asieris Pharmaceuticals has released its 2026 Semi-Annual Report, highlighting progress in commercial operations, international...

Hong Kong, August 21, 2026 Akeso, Inc. has announced that its investigational B7-H3-targeting antibody-drug conjugate (ADC), AK157D1, has received...

Cambridge, Massachusetts; Rotterdam, Netherlands; and Shanghai, China, August 18, 2026 Harbour BioMed (HKEX: 02142) announced that China’s National Medical...

Shanghai, China, August 12, 2026 Shanghai Ark Biopharmaceutical Co., Ltd. (ArkBio) announced that China’s National Medical Products Administration (NMPA)...

SHANGHAI, China, August 12, 2026 Laekna announced that China’s National Medical Products Administration (NMPA) has accepted the New Drug...

SHANGHAI, August 7, 2026 Alebund Pharmaceuticals announced that China’s National Medical Products Administration (NMPA) has formally accepted for review...